Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Publication year range
1.
Clin Chim Acta ; 451(Pt B): 165-9, 2015 Dec 07.
Article in English | MEDLINE | ID: mdl-26409785

ABSTRACT

BACKGROUND: Despite accumulating evidence suggesting the clinical association between serum ferritin concentrations and diabetes, it is not clearly identified in other ethnic groups besides western population. This study analyzed a longitudinal relationship between serum ferritin concentration and the risk for diabetes in non-diabetic Korean men. METHODS: This study was composed of a cohort of 30,002 non-diabetic Korean men who participated in medical health check-up program in 2005. They were divided into 4 groups according to their baseline ferritin concentrations (first quartile-fourth quartile) and monitored until 2010. Their incidences and hazard ratios of diabetes were compared among 4 groups according to their baseline ferritin concentrations. RESULTS: While 2655 cases of diabetes newly developed during follow-up, incidence of diabetes increased proportionally to the baseline serum ferritin concentrations. In Cox-proportional hazard model, hazard ratios for diabetes also independently increased according to the baseline serum ferritin concentrations [quartile 1: 1.00 (reference), quartile 2: 1.00 (0.87-1.12), quartile 3: 1.13 (1.00-1.29), quartile 4: 1.18 (1.04-1.34), respectively]. CONCLUSIONS: Increased ferritin concentration was associated with increased risk for diabetes in Korean men. These findings suggest the clinical significance of serum ferritin concentration in the development diabetes.


Subject(s)
Diabetes Mellitus, Type 2/blood , Ferritins/blood , Adult , Humans , Male , Republic of Korea , Risk Factors
2.
Intervirology ; 57(6): 337-43, 2014.
Article in English | MEDLINE | ID: mdl-25247889

ABSTRACT

OBJECTIVES: This study investigated the antiviral efficacy of adefovir (ADV) rescue therapy and the feasibility of lamivudine (LAM) discontinuation in LAM-resistant chronic hepatitis B (CH-B) patients who had attained a virological response (VR) with LAM + ADV combination therapy. METHODS: The VR and virological breakthrough (VBT) were analyzed in 106 consecutively enrolled LAM-resistant CH-B patients who received ADV rescue therapy during a mean follow-up period of 55.2 months. Seventy-four patients achieved VR, and were divided into the LAM-discontinuation group (n = 39) and the LAM-continuation group (n = 35). The VR and VBT between the 2 groups were compared. RESULTS: For all 106 LAM-resistant CH-B patients, the overall cumulative probabilities of VR at 1, 2, 3 and 5 years of ADV rescue therapy were 40.6, 55.7, 64.6 and 81.3%, respectively. The cumulative probabilities of VBT at 1, 2, 3 and 5 years were 0, 2.9, 8.8 and 13.9%, respectively. Whether they discontinued or continued LAM after achieving VR on LAM + ADV therapy, VR and VBT were not significantly different during a mean follow-up period of 40.4 months. CONCLUSIONS: There was a good long-term VR with ADV rescue therapy for LAM-resistant CH-B patients. Moreover, discontinuing LAM was found to be feasible for patients who attained VR during ADV + LAM therapy.


Subject(s)
Adenine/analogs & derivatives , Antiviral Agents/administration & dosage , Hepatitis B, Chronic/drug therapy , Lamivudine/administration & dosage , Organophosphonates/administration & dosage , Adenine/administration & dosage , Adult , DNA, Viral/blood , Drug Resistance, Viral , Drug Therapy, Combination , Feasibility Studies , Female , Hepatitis B virus/drug effects , Hepatitis B virus/genetics , Hepatitis B, Chronic/virology , Humans , Male , Middle Aged , Multivariate Analysis , Retrospective Studies , Treatment Outcome , Young Adult
3.
Dig Dis Sci ; 59(12): 2967-74, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25069572

ABSTRACT

BACKGROUND: The role of the patatin-like phospholipase domain-containing 3 (PNPLA3) single-nucleotide polymorphism (SNP), rs738409, in the development and progression of nonalcoholic fatty liver disease (NAFLD) has not been studied in the Korean population. AIMS: The aim of the study was to investigate the genotype frequency and allele distribution of PNPLA3 rs738409 and the association between the SNP and development of NAFLD and liver fibrosis. METHODS: A total of 339 Korean adults (155 NAFLD patients and 184 healthy controls) were enrolled. PNPLA3 SNP genotyping was carried out using a TaqMan allelic discrimination assay. Liver fibrosis severity was evaluated by NAFLD fibrosis score (NFS) and BARD score. RESULTS: The frequencies of the PNPLA3 rs738409 genotypes, CC, CG, and GG in the healthy control group were 29.9, 50.0, and 20.1%, respectively, and those in NAFLD patients were 20.0, 48.4, and 31.6%, respectively, showing a higher frequency of the risk allele (G allele) (p = 0.006). Among the NAFLD patients, the CG+GG genotype frequency was significantly higher in patients with advanced fibrosis, defined as NFS ≥ -1.455 or BARD score ≥2, than in patients with mild-to-moderate fibrosis (p = 0.012 and p = 0.046, respectively). In multivariate analysis, the CG+GG genotype was an independent factor for NAFLD development (odds ratio 2.568, 95% CI 1.109-5.945, p = 0.028) and for advanced liver fibrosis according to the criteria of NFS ≥ -1.455 (odds ratio 18.573, 95% CI 2.035-169.526, p = 0.010) or a BARD score ≥2 (odds ratio 4.040, 95% CI 1.084-15.048, p = 0.037). CONCLUSION: The PNPLA3 rs738409 polymorphism is common and may confer a significant risk of NAFLD and advanced liver fibrosis in the Korean population.


Subject(s)
Genetic Predisposition to Disease , Lipase/metabolism , Liver Cirrhosis/genetics , Membrane Proteins/metabolism , Non-alcoholic Fatty Liver Disease/genetics , Polymorphism, Genetic , Adult , Case-Control Studies , Female , Genotype , Humans , Lipase/genetics , Liver Cirrhosis/epidemiology , Male , Membrane Proteins/genetics , Middle Aged , Non-alcoholic Fatty Liver Disease/epidemiology , Odds Ratio , Republic of Korea/epidemiology
4.
Gut Liver ; 8(1): 70-8, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24516704

ABSTRACT

BACKGROUND/AIMS: This study investigated the role of single nucleotide polymorphisms (SNPs) near the interleukin-28B (IL28B) gene with respect to clinical outcomes and the antiviral response in hepatitis C virus (HCV) infection to suggest the practical utility of IL28B genotyping in Korea. METHODS: Two SNPs near IL28B, rs12979860 and rs8099917, were analyzed using an allelic discrimination assay in a total of 454 individuals, including 147 health-check examinees and 307 patients with HCV infection. RESULTS: The CC genotype frequency was significantly higher in the spontaneous recovery group than in the chronic infection group and was higher in the chronic hepatitis group than in the liver cirrhosis or hepatocellular carcinoma group, suggesting its favorable role in the clinical outcome. Multivariate analysis revealed that the rs12979860 CC genotype was an independent predictor of sustained virologic response (SVR) in genotype 1 HCV infection. During the currently used response-guided therapy, IL28B genotyping was most helpful for the patients who exhibit early virologic responses without rapid virologic responses, as those patients exhibiting the non-CC type did not achieve SVR, although they represented approximately one-third of the total patients. CONCLUSIONS: The IL28B SNP is an independent predictor of SVR. Our results may be helpful if the findings are carefully applied to select patients in Korea.


Subject(s)
Carcinoma, Hepatocellular/genetics , Hepatitis C, Chronic/genetics , Interleukins/genetics , Liver Cirrhosis/genetics , Liver Neoplasms/genetics , Adult , Aged , Aged, 80 and over , Female , Humans , Interferons , Male , Middle Aged , Polymorphism, Single Nucleotide , Prognosis , Republic of Korea , Retrospective Studies
5.
BMC Cancer ; 13: 335, 2013 Jul 08.
Article in English | MEDLINE | ID: mdl-23829392

ABSTRACT

BACKGROUND: Cryptogenic hepatocellular carcinoma (HCC) is thought to arise due to non-alcoholic fatty liver disease (NAFLD). This study investigated the prevalence, clinical features, and outcomes of cryptogenic HCC and compared them with those of HCC related to hepatitis B virus infection (HBV-HCC), hepatitis C virus infection (HCV-HCC), and alcohol (ALC-HCC) in Korea. METHODS: The clinical features, treatment modalities, and survival data for 480 patients with HCC consecutively enrolled from January 2003 to June 2012 were analyzed. Computed tomography images were used to measure the visceral fat area (VFA) and liver-spleen density ratio. RESULTS: Cryptogenic HCC accounted for 6.8% of all HCC cases, whereas HBV-HCC, HCV-HCC, and ALC-HCC accounted for 62.7%, 13.5%, and 10.7% of HCC cases, respectively. The cryptogenic HCC group was characterized by older age, a low proportion of male patients, a high proportion of patients with metabolic syndrome or single nodular presentation, and a low proportion of patients with portal vein invasion compared to the viral-HCC and ALC-HCC groups. However, Child Pugh classes, tumor stages, and overall survival rates of cryptogenic HCC patients were similar to those of patients with HCC of other etiologies. VFA in cryptogenic HCC patients was significantly higher than that in viral-HCC patients, but similar to that in ALC-HCC patients. The liver-spleen density ratio did not vary according to HCC etiology. CONCLUSIONS: Cryptogenic HCC accounts for approximately 7% of HCC cases in Korea, associated with an older age at diagnosis, more frequent occurrence of metabolic syndrome, and less aggressive tumor characteristics, but similar survival compared to viral-HCC or ALC-HCC. Based on VFA and the liver-to-spleen density ratio, cryptogenic HCC may be burnt-out NAFLD in which visceral fat remains but liver fat is depleted.


Subject(s)
Carcinoma, Hepatocellular/etiology , Carcinoma, Hepatocellular/pathology , Liver Neoplasms/etiology , Liver Neoplasms/pathology , Aged , Alcoholism/complications , Carcinoma, Hepatocellular/epidemiology , Fatty Liver/complications , Female , Hepatitis B/complications , Hepatitis C/complications , Humans , Liver Neoplasms/epidemiology , Male , Middle Aged , Non-alcoholic Fatty Liver Disease , Prevalence
6.
Clin Mol Hepatol ; 18(3): 309-15, 2012 Sep.
Article in English | MEDLINE | ID: mdl-23091812

ABSTRACT

BACKGROUND/AIMS: The aim of this study was to describe the types and causes of liver disease in patients from a single community hospital in Korea between April 2005 and May 2010. METHODS: A cohort of patients who visited the liver clinic of the hospital during the aforementioned time period were consecutively enrolled (n=6,307). Consistent diagnostic criteria for each liver disease were set by a single, experienced hepatologist, and the diagnosis of all of the enrolled patients was confirmed by retrospective review of their medical records. RESULTS: Among the 6,307 patients, 528 (8.4%) were classified as acute hepatitis, 3,957 (62.7%) as chronic hepatitis, 767 (12.2%) as liver cirrhosis, 509 (8.1%) as primary liver cancer, and 546 (8.7%) as a benign liver mass or other diseases. The etiologies in the acute hepatitis group in decreasing order of prevalence were hepatitis A (44.3%), toxic hepatitis (32.4%), other hepatitis viruses (13.8%), and cryptogenic hepatitis (9.1%). In the chronic hepatitis group, 51.2% of cases were attributed to viral hepatitis, 33.3% to nonalcoholic fatty liver disease, and 13.0% to alcoholic liver disease (ALD). Of the cirrhoses, 73.4% were attributable to viral causes and 18.1% to alcohol. Of the hepatocellular carcinoma cases, 86.6% were attributed to viral hepatitis and 11.6% to ALD. Among the benign tumors, hemangioma comprised 52.2% and cystic liver disease comprised 33.7%. CONCLUSIONS: Knowledge of the current status of the type and cause of liver disease in Korea may be valuable as a basis for evaluating changing trends in liver disease in that country.


Subject(s)
Liver Diseases/diagnosis , Acute Disease , Adolescent , Adult , Aged , Aged, 80 and over , Alcohol Drinking/adverse effects , Carcinoma, Hepatocellular/epidemiology , Carcinoma, Hepatocellular/etiology , Carcinoma, Hepatocellular/pathology , Chronic Disease , Cohort Studies , Fatty Liver/epidemiology , Female , Hepatitis/epidemiology , Hepatitis, Viral, Human/complications , Hepatitis, Viral, Human/epidemiology , Humans , Liver Cirrhosis/epidemiology , Liver Cirrhosis/etiology , Liver Diseases/epidemiology , Liver Diseases, Alcoholic/complications , Liver Diseases, Alcoholic/epidemiology , Liver Neoplasms/epidemiology , Liver Neoplasms/etiology , Liver Neoplasms/pathology , Male , Middle Aged , Non-alcoholic Fatty Liver Disease , Prevalence , Republic of Korea/epidemiology , Retrospective Studies , Young Adult
7.
Korean J Gastroenterol ; 59(6): 414-22, 2012 Jun 25.
Article in Korean | MEDLINE | ID: mdl-22735874

ABSTRACT

BACKGROUND/AIMS: The aim of this study was to compare polyethylene glycol (PEG) 4 L, split method of PEG 4 L and PEG 2 L plus sodium phosphate (NaP) in the aspect of bowel preparation quality, safety, patients' compliance and preference. METHODS: Total 249 subjects were prospectively enrolled and received bowel preparation for colonoscopy from August to October in 2010; PEG 4 L (93 subjects), split method of 4 L PEG (74 subjects) and PEG 2 L plus NaP 90 mL group (82 subjects). To investigate the completion, preference for bowel preparation and safety, a questionnaire survey was conducted before colonoscopy. RESULTS: There were no significant intergroup differences in the aspect of completion of preparation, cecal intubation time and success rate. Satisfaction and preference were higher in PEG 2 L plus NaP 90 mL and split method of 4 L PEG compared with PEG 4 L. In the aspect of the bowel preparation quality PEG 4 L showed significantly higher quality in the morning colonoscopy (p<0.001). However, in the afternoon colonoscopy PEG 2 L plus NaP 90 mL showed better result than PEG 4 L (p=0.009). Hyperphosphatemia was most frequently observed in PEG 2 L plus NaP 90 mL, but no severe adverse events occurred (p<0.001). CONCLUSIONS: PEG 4 L showed better result than split method of 4 L PEG or PEG 2 L plus NaP 90 mL in the aspect of bowel preparation quality and safety.


Subject(s)
Cathartics/pharmacology , Colon/drug effects , Phosphates/pharmacology , Polyethylene Glycols/pharmacology , Adult , Aged , Cathartics/adverse effects , Colon/anatomy & histology , Colonoscopy , Female , Humans , Hyperphosphatemia/etiology , Male , Middle Aged , Patient Compliance , Phosphates/adverse effects , Polyethylene Glycols/adverse effects , Prospective Studies , Surveys and Questionnaires , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...